Results 151 to 160 of about 34,583 (167)

[Different Types of Obesity Play a Modifying Role in the Association Between Physical Activity and Metabolic Dysfunction-Associated Fatty Liver Disease]. [PDF]

Sichuan Da Xue Xue Bao Yi Xue Ban
Chang Y, Li J, Wu G, Zhang J, Guo B, Zhao X.   +5 more
europepmc   +1 more source

Factors influencing the use of weight management APP among obese patients in Chinese cities in the post-epidemic era. [PDF]

Zhong Nan Da Xue Xue Bao Yi Xue Ban
Qu S, Yan W, Zhou M, He W.
europepmc   +1 more source

[Research progress of probiotics regulating intestinal micro-ecological environment in obese patients after bariatric surgery]. [PDF]

Zhejiang Da Xue Xue Bao Yi Xue Ban
Zhang X, Wu M, Wang J, Chen J, Yu W, Pan H.   +5 more
europepmc   +1 more source

[A randomized controlled trial of weight management based on mobile health techno-logy among overweight or obese pregnant women]. [PDF]

Beijing Da Xue Xue Bao Yi Xue Ban
Li P, Wang H, Gao X, Han Y, Wang H, Wang H, Mu Y.   +6 more
europepmc   +1 more source

Correlation between obesity and early vascular aging in middle-aged and young adult health check-up populations. [PDF]

Zhong Nan Da Xue Xue Bao Yi Xue Ban
Zhao L, Cui M, Li Y, Li Y, Miao R, Wang J, Zhou H.   +6 more
europepmc   +1 more source

[Impact of arsenic exposure on the hepatic metabolic molecular network in obese pregnant mice using metabolomics and proteomics]. [PDF]

Se Pu
Cai LJ, Wang Y, Tan JF, Zhou HX, Liang SJ, Wu Y, Zhang J.   +6 more
europepmc   +1 more source

[Reoxygenation improves reduced hypothalamic leptin responsiveness induced by intermittent hypoxia in obese rats]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Dong M, Zhu T, Ma J, DU X, Feng Y.
europepmc   +1 more source

[Synthetic phenolic compounds perturb lipid metabolism and induce obesogenic effects]. [PDF]

Se Pu
Liu HN, Sun ZD, Liu Q, Zhou QF, Jiang GB.   +4 more
europepmc   +1 more source

Association of whole blood copper, zinc, calcium, magnesium, and iron with non-alcoholic fatty liver disease in overweight and obese children. [PDF]

Zhong Nan Da Xue Xue Bao Yi Xue Ban
Huang Z, Luo M, Dai W, Yao Z, Ouyang S, Xu N, Zhou H, Li X, Zhong Y, Luo J.   +9 more
europepmc   +1 more source

EGR3 reduces podocyte inflammatory damage in obesity related glomerulopathy by inhibiting the PRMT1/p-STAT3 pathway. [PDF]

Zhong Nan Da Xue Xue Bao Yi Xue Ban
Peng L, Sun X, Yi X, Wang Z, Chen K.
europepmc   +1 more source